Document:

Exhibit 10.1

 

Exhibit 10.1

WEBSIDESTORY, INC.

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY

(Amended as of April 20, 2005 and September 28, 2006)

     Certain non-employee members of the board of directors (the “Board”) of WebSideStory, Inc.
(the “Company”) are eligible to receive (x) cash compensation as set forth in Section 7 below and
(y) equity compensation following the first date upon which the Company’s common stock is listed
(or approved for listing) upon notice of issuance on any securities exchange or designated (or
approved for designation) upon notice of issuance as a national market security on an interdealer
quotation system (the “Public Trading Date”) as set forth in this Non-Employee Director
Compensation Policy (this “Policy”). The option grants described in this Policy will be made
automatically, and without further action of the Board, to each non-employee director who may be
eligible to receive such options unless such non-employee director declines the receipt of such
options by notice to the Company. This Policy will remain in effect until it is revised or
rescinded by further action of the Board.

     The options described below will be granted under and will be subject to the terms and
provisions of the Company’s 2004 Equity Incentive Award Plan (the “2004 Plan”). The options
described below will be granted subject to the execution and delivery of option agreements,
including attached exhibits, in substantially the same forms previously approved by the Board,
setting forth the vesting schedule applicable to such options and such other terms as may be
required by the 2004 Plan.

     All share numbers set forth in this Policy give effect to the reverse stock split to be
implemented by the Company in connection with its initial public offering.

          1. Eligibility. All non-employee members of the Board will be eligible to receive
cash and options as described in this Policy. The Board, in its sole discretion, will determine
whether a non-employee director is eligible for an option grant pursuant to this Policy.

          2. Initial Options. (i) A person who is a non-employee director as of the Public
Trading Date and who does not hold any options to purchase shares of the Company’s common stock on
such date shall be eligible to receive a non-qualified stock option to purchase 35,000 shares of
common stock (subject to adjustment as provided in the 2004 Plan) on the Public Trading Date, and
(ii) a person who is initially elected to the Board following the Public Trading Date and who is a
non-employee director at the time of such initial election, will be eligible to receive a
non-qualified stock option to purchase 35,000 shares of the Company’s common stock (subject to
adjustment as provided in the 2004 Plan) on the date of such initial election (each, an “Initial
Option”).

          3. Subsequent Options. Once any person who is a non-employee director becomes fully
vested in his or her outstanding option grants (including a non-employee director serving on the
Board as of the Public Trading Date who does not receive an Initial Option and any

1

 

non-employee director who becomes eligible to receive options under this Policy pursuant to
paragraph 4 below), he or she will be eligible to receive a non-qualified stock option to purchase
35,000 shares of the Company’s common stock (subject to adjustment as provided in the 2004 Plan) on
the first day after his or her outstanding option grants become fully vested (each, a “Subsequent
Option”); provided, however, that a Subsequent Option will not be granted in the
event a non-employee director’s outstanding option grants become fully vested in connection with a
Change in Control (as defined in the 2004 Plan), the non-employee director’s termination of service
as a member of the Board or as a result of another non-recurring transaction, in each case as
determined by the Board in its sole discretion.

          4. Options to Audit Committee Chairman. (i) The person who is serving as the chairman
of the audit committee of the Board as of April 20, 2005 will be eligible to receive a
non-qualified stock option to purchase 20,000 shares of the Company’s common stock (subject to
adjustment as provided in the 2004 Plan) on such date, and (ii) a person who is initially elected
to serve as the chairman of the audit committee of the Board following April 20, 2005 will be
eligible to receive a non-qualified stock option to purchase 20,000 shares of the Company’s common
stock (subject to adjustment as provided in the 2004 Plan) on the date of such initial election,
which option shall be in addition to any option granted to such person pursuant to paragraph 2
above. Once any option pursuant to this paragraph 4 becomes fully vested, if the person holding
such option is still serving as the chairman of the audit committee of the Board on such date, he
or she will be eligible to receive a non-qualified stock option to purchase 20,000 shares of the
Company’s common stock (subject to adjustment as provided in the 2004 Plan) on the first day after
his or her outstanding option granted pursuant to this paragraph 4 becomes fully vested;
provided, however, that no option will be granted in the event a non-employee
director’s outstanding option granted pursuant to this paragraph 4 becomes fully vested in
connection with a Change in Control (as defined in the 2004 Plan), the non-employee director’s
termination of service as a member of the Board or as a result of another non-recurring
transaction, in each case as determined by the Board in its sole discretion.

          5. Retirement of Employee Directors. Members of the Board who are employees of the
Company who subsequently retire from the Company and remain on the Board will be eligible to
receive, after retirement from employment with the Company, options as described in paragraph 3
above and cash compensation as described in paragraph 7 below.

          6. Terms of Options Granted to Non-Employee Directors.

               (a) Exercise Price. The per share price of each option granted to a non-employee
director pursuant to this Policy will equal 100% of the fair market value of a share of the
Company’s common stock on the date the option is granted (as determined under the 2004 Plan).

               (b) Vesting. Options granted to non-employee directors pursuant to this Policy will
become vested and exercisable as follows: 25% of the total number of shares subject to each option
(rounded down to the nearest whole share) will vest on the one year anniversary of the date of
grant and 1/48th of the total number of shares subject to each option (rounded down to
the nearest whole share) will vest in equal monthly installments on each monthly anniversary of the
date of grant thereafter, such that each option will be 100% vested on the fourth anniversary of
its

2

 

date of grant, subject to a director’s continuing service on the Board through such dates.
The term of each option granted to a non-employee director pursuant to this Policy will be ten
years from the date the option is granted. No portion of an option granted pursuant to this Policy
which is unexercisable at the time of a non-employee director’s termination of membership on the
Board will thereafter become exercisable.

          7. Cash Compensation to Non-Employee Directors.

               (a) Effective as of the quarter ended September 30, 2006, the Company will pay to each
non-employee director $25,000 annually, and each such non-employee director will also be eligible
to receive additional cash payments of (x) $10,000 annually for serving as the chair of (i) the
Audit Committee, (ii) the Compensation Committee or (iii) the Nominating/Corporate Governance
Committee and (y) $5,000 annually for being a member (other than the chair) of (i) the Audit
Committee, (ii) the Compensation Committee or (iii) the Nominating/Corporate Governance Committee,
provided that in no event will any non-employee director be eligible to receive more than $35,000
in a calendar year for such board and committee service.

               (b) Such amounts will be paid by the Company to each non-employee director quarterly in
arrears, provided that a non-employee director will not be eligible to receive such payments unless
such non-employee director was a member of the board or a committee for the entire quarter, as
applicable.

3EX-10.1

 

Exhibit 10.1

 

MERCK & CO., INC.

PLAN FOR DEFERRED PAYMENT OF

DIRECTORS’ COMPENSATION

(Amended and Restated as of October 1, 2006)

 

 

 

TABLE OF CONTENTS

	 	 	 	 	 	 	 
	 	 	 	 	Page
	Article I

	 	Purpose
	 	 	1	 
	Article II

	 	Election of Deferral, Measurement Methods and Distribution Schedule
	 	 	1	 
	Article III

	 	Valuation of Deferred Amounts
	 	 	2	 
	Article IV

	 	Redesignation Within a Deferral Account
	 	 	4	 
	Article V

	 	Payment of Deferred Amounts
	 	 	5	 
	Article VI

	 	Designation of Beneficiary
	 	 	6	 
	Article VII

	 	Plan Amendment or Termination
	 	 	6	 
	Schedule A

	 	Measurement Methods
	 	 	7	 

(i)

 

MERCK & CO., INC.

PLAN FOR DEFERRED PAYMENT OF

DIRECTORS’ COMPENSATION

	I.	 	PURPOSE
	 
	 	 	To provide an arrangement under which directors of Merck & Co., Inc. other than
current employees may (i) elect to voluntarily defer payment of annual retainers and Board
and committee meeting fees until after termination of their service as a director, and (ii)
value compensation mandatorily deferred on their behalf.
	 
	II.	 	ELECTION OF DEFERRAL, MEASUREMENT METHODS AND
DISTRIBUTION SCHEDULE

	 	A.	 	Election of Voluntary Deferral Amount
	 
	 	1.	 	Prior to December 28 of each year, each director is entitled to make an
irrevocable election to defer until termination of service as a director receipt of
payment of (a) 50% or 100% of the Board retainer for the 12 months beginning April 1
of the next calendar year, (b) 50% or 100% of the Committee Chairperson retainer for
the 12 months beginning April 1 of the next calendar year, (c) 50% or 100% of the
Audit Committee member retainer for the 12 months beginning April 1 of the next
calendar year and (d) 50% or 100% of the Board and committee meeting fees for the 12
months beginning April 1 of the next calendar year.
	 
	 	2.	 	Prior to commencement of duties as a director, a director newly elected or
appointed to the Board during a calendar year must make the election under this
paragraph for the portion of the Voluntary Deferral Amount applicable to such
director’s first year of service (or part thereof).
	 
	 	3.	 	The Voluntary Deferral Amount shall be credited as follows: (1) Board and
committee meeting fees that are deferred are credited on the last business day of each
calendar quarter; (2) if the Board retainer, Committee Chairperson retainer and/or
Audit Committee member retainer are deferred, a pro-rata share of the deferred
retainer is credited on the last business day of each calendar quarter. The dates the
Voluntary Deferral Amount, or parts thereof, are credited to the director’s deferred
account are hereinafter referred to as the Voluntary Deferral Dates.
	 
	 	B.	 	Mandatory Deferral Amount
	 
	 	1.	 	On the Friday following the Company’s Annual Meeting of Stockholders (such
Friday hereinafter referred to as the “Mandatory Deferral Date”), each director will
be credited with an amount equivalent to the annual cash retainer for the 12 month
period beginning on the April 1 preceding the Annual Meeting (the “Mandatory Deferral
Amount”). The Mandatory Deferral Amount will be measured by the Merck Common Stock
account.
	 
	 	2.	 	A director newly elected or appointed to the Board after the Mandatory
Deferral Date will be credited with a pro rata portion of the Mandatory Deferral
Amount

 

 

	 	 	 	applicable to such director’s first year of service (or part thereof). Such pro
rata portion shall be credited to the director’s account on the first day of such
director’s service.
	 
	 	C.	 	Automatic Deferral of Executive Committee Fees
	 
	 	1.	 	Effective June 1, 2005, any director who serves as either Chairperson or
member of the Board’s Executive Committee, in lieu of any cash payment for such
service, will be credited with an amount, if any, provided by way of retainer or
meeting fees (the “Automatic Deferral Amount”). The Automatic Deferral Amount will be
measured by the Merck Common Stock account.
	 
	 	2.	 	The “Automatic Deferral Date” with respect to meeting fees will be the last
business day of each calendar quarter during which such meetings occurred. The
“Automatic Deferral Date” for Committee Chairperson retainer and/or Committee member
retainer fees, which are annual fees paid quarterly, will be the last business day of
each calendar quarter.
	 
	 	D.	 	Election of Measurement Method
	 
	 	 	 	Each such annual election referred to in Section A shall include an election as to
the measurement method or methods by which the value of amounts deferred will be
measured in accordance with Article III, below. The available measurement methods
are set forth on Schedule A hereto.
	 
	 	E.	 	Election of Distribution Schedule
	 
	 	 	 	Each annual election referred to in Article II, Sections A, B and C shall also
include an election to receive payment following termination of service as a
director of all Voluntary Deferral Amounts Mandatory Deferral Amounts and Automatic
Deferral Amounts in a lump sum either immediately or one year after such
termination, or in quarterly or annual installments over five, ten or fifteen
years. Any election made with respect to a Mandatory Deferral Amount also shall
apply with respect to any Automatic Deferral Amount credited during the same
period.

III. VALUATION OF DEFERRED AMOUNTS

	 	A.	 	Common Stock
	 
	 	1.	 	Initial Crediting. The annual Mandatory Deferral Amount shall be used to
determine the number of full and partial shares of Merck Common Stock which such
amount would purchase at the closing price of the Common Stock on the New York Stock
Exchange on the Mandatory Deferral Date.
	 
	 	 	 	The Automatic Deferral Amount shall be used to determine the number of full and
partial shares of Merck Common Stock which such amount would purchase at the
closing price of the Common Stock on the New York Stock Exchange on the Automatic
Deferral Date.

2

 

	 	 	 	That portion of the Voluntary Deferral Amount allocated to Merck Common Stock shall
be used to determine the number of full and partial shares of Merck Common Stock
which such amount would purchase at the closing price of the Common Stock on the
New York Stock Exchange on the applicable Voluntary Deferral Date.
	 
	 	 	 	However, should it be determined by the Committee on Corporate Governance of the
Board of Directors that a measurement of Merck Common Stock on any Mandatory,
Automatic or Voluntary Deferral Date would not constitute fair market value, then
the Committee shall decide on which date fair market value shall be determined
using the valuation method set forth in this Article III, Section A.1.
	 
	 	 	 	At no time during the deferral period will any shares of Merck Common Stock be
purchased or earmarked for such deferred amounts nor will any rights of a
shareholder exist with respect to such amounts.
	 
	 	2.	 	Dividends. Each director’s account will be credited with the additional
number of full and partial shares of Merck Common Stock which would have been
purchasable with the dividends on shares previously credited to the account at the
closing price of the Common Stock on the New York Stock Exchange on the date each
dividend was paid.
	 
	 	3.	 	Distributions. Distribution from the Merck Common Stock account will be
valued at the closing price of Merck Common Stock on the New York Stock Exchange on
the distribution date.
	 
	 	B.	 	Mutual Funds
	 
	 	1.	 	Initial Crediting. The amount allocated to each Mutual Fund shall be used to
determine the full and partial Mutual Fund shares which such amount would purchase at
the closing net asset value of the Mutual Fund shares on the Mandatory or Voluntary
Deferral Date, whichever is applicable. The director’s account will be credited with
the number of full and partial Mutual Fund shares so determined.
	 
	 	 	 	At no time during the deferral period will any Mutual Fund shares be purchased or
earmarked for such deferred amounts nor will any rights of a shareholder exist with
respect to such amounts.
	 
	 	2.	 	Dividends. Each director’s account will be credited with the additional
number of full and partial Mutual Fund shares which would have been purchasable, at
the closing net asset value of the Mutual Fund shares as of the date each dividend is
paid on the Mutual Fund shares, with the dividends which would have been paid on the
number of shares previously credited to such account (including pro rata dividends on
any partial shares).
	 
	 	3.	 	Distributions. Mutual Fund distributions will be valued based on the closing
net asset value of the Mutual Fund shares on the distribution date.

3

 

	 	C.	 	Adjustments
	 
	 	 	 	In the event of a reorganization, recapitalization, stock split, stock dividend,
combination of shares, merger, consolidation, rights offering or any other change
in the corporate structure or shares of the Company or a Mutual Fund, the number
and kind of shares or units of such investment measurement method available under
this Plan and credited to each director’s account shall be adjusted accordingly.

IV. REDESIGNATION WITHIN A DEFERRAL ACCOUNT

	 	A.	 	General
	 
	 	 	 	A director may request a change in the measurement methods used to value all or a
portion of his/her account other than Merck Common Stock. Amounts deferred using
the Merck Common Stock method and any earnings attributable to such deferrals may
not be redesignated. The change will be effective on (i) the day when the
redesignation request is received pursuant to administrative guidelines established
by the Human Resources Financial Services area of the Treasury department, provided
the request is received prior to the close of the New York Stock Exchange on such
day or (ii) the next following business day if the request is received when the New
York Stock Exchange is closed.
	 
	 	B.	 	When Redesignation May Occur
	 
	 	1.	 	During Active Service. There is no limit on the number of times a director
may redesignate the portion of his/her deferred account permitted to be redesignated.
Each such request shall be irrevocable and can be designated in whole percentages or
as a dollar amount.
	 
	 	2.	 	After Death. Following the death of a director, the legal representative or
beneficiary of such director may redesignate subject to the same rules as for active
directors set forth in Article IV, Section B.1.
	 
	 	C.	 	Valuation of Amounts to be Redesignated 
	 
	 	 	 	The portion of the director’s account to be redesignated will be
valued at its cash equivalent and such cash equivalent will be converted into shares or units of the
other measurement method(s). For purposes of such redesignations, the cash
equivalent of the value of the Mutual Fund shares shall be the closing net asset
value of such Mutual Fund on (i) the day when the redesignation request is received
pursuant to administrative guidelines established by the Human Resources Financial
Services area of the Treasury department, provided the request is received prior to
the close of the New York Stock Exchange on such day or (ii) the next following
business day if the request is received when the New York Stock Exchange is closed.

4

 

V. PAYMENT OF DEFERRED AMOUNTS

	 	A.	 	Payment
	 
	 	 	 	All payments to directors of amounts deferred will be in cash in accordance with
the distribution schedule elected by the director pursuant to Article II, Section
E. Distributions shall be pro rata by measurement method. Distributions shall be
valued on the fifteenth day of the distribution month (or, if such day is not a
business day, the next business day) and paid as soon thereafter as possible.
	 
	 	B.	 	Changes to Distribution Schedule Prior to Termination
	 
	 	 	 	Upon the request of a director made at any time during the calendar year
immediately preceding the calendar year in which service as a director is expected
to terminate, the Committee on Corporate Governance of the Board of Directors (the
“Committee”), in its sole discretion, may authorize: (a) an extension of a payment
period beyond that originally elected by the director not to exceed that otherwise
allowable under Article II, Section E, and/or (b) a payment frequency different
from that originally elected by the director. Such request may not be made with
regard to amounts deferred after December 31, 1990 using the Merck Common Stock
method and to any earnings attributable to such deferrals. Deferrals into Merck
Common Stock made after December 31, 1990 and any earnings thereon may only be
distributed in accordance with the schedule elected by the director under Article
II, Section E or determined by the Committee on Corporate Governance under Article
VI.
	 
	 	C.	 	Post-Termination Changes to Distribution Schedule
	 
	 	 	 	Following termination of service as a director, each director may make one request
for a further extension of the period for distribution of his/her deferred
compensation. Such request must be received by the Committee on Corporate
Governance prior to the first distribution to the participant under his/her
previously elected distribution schedule. Any revised distribution schedule may
not exceed the deferral period otherwise allowable under Article II, Section E.
This request may be granted and a new payment schedule determined in the sole
discretion of the Committee on Corporate Governance.
	 
	 	 	 	Such request may not be made with regard to amounts deferred after December 31,
1990 using the Merck Common Stock Method and to any earnings attributable to such
deferrals. Any retired director who is not subject to U.S. income tax may petition
the Committee on Corporate Governance to change payment frequency, including a lump
sum distribution, and the Committee on Corporate Governance may grant such petition
if, in its discretion, it considers there to be reasonable justification therefor.
Deferrals into Merck Common Stock made after December 30, 1990 and any earnings
thereon may only be distributed in accordance with the schedule elected by the
director under Article II, Section E or determined by the Committee on Corporate
Governance under Article VI.

5

 

	 	D.	 	Forfeitures
	 
	 	 	 	A director’s deferred amount attributable to the Mandatory Deferral Amount and
earnings thereon shall be forfeited upon his or her removal as a director or upon a
determination by the Committee on Corporate Governance in its sole discretion, that
a director has:

	 	(i)	 	joined the Board of, managed, operated, participated in a
material way in, entered employment with, performed consulting (or any other)
services for, or otherwise been connected in any material manner with a
company, corporation, enterprise, firm, limited partnership, partnership,
person, sole proprietorship or any other business entity determined by the
Committee on Corporate Governance in its sole discretion to be competitive
with the business of the Company, its subsidiaries or its affiliates (a
“Competitor”);
	 
	 	(ii)	 	directly or indirectly acquired an equity interest of 5
percent or greater in a Competitor; or
	 
	 	(iii)	 	disclosed any material trade secrets or other material
confidential information, including customer lists, relating to the Company or
to the business of the Company to others, including a Competitor.

	VI.	 	DESIGNATION OF BENEFICIARY
	 
	 	 	In the event of the death of a director, the deferred amount at the date of death
shall be paid to the last named beneficiary or beneficiaries designated by the director,
or, if no beneficiary has been designated, to the director’s legal representative, in one
or more installments as the Committee on Corporate Governance in its sole discretion may
determine.
	 
	VII.	 	PLAN AMENDMENT OR TERMINATION
	 
	 	 	The Committee on Corporate Governance shall have the right to amend or terminate this
Plan at any time for any reason.

6

 

SCHEDULE A

MEASUREMENT METHODS

(January 1,
2002 — January 10, 2003)

Merck Common Stock

Mutual Funds

American Century Emerging Markets Fund

American Century Europacific Growth Fund

Fidelity Destiny I

Fidelity Dividend Growth

Fidelity Equity Income Fund

Fidelity Low-Priced Stock Fund

Fidelity Retirement Money Market

Fidelity Spartan Government Income

Fidelity Spartan U.S. Equity Index

Franklin Small-Mid Cap Growth A

Janus Enterprise

Janus Growth & Income

Liberty Acorn Z

PIMCO Foreign Bond Institutional

PIMCO Long Term US Government Institutional

PIMCO Total Return Institutional

Putnam Global Equity Fund A*

Putnam International Voyager A

Putnam Vista A

T. Rowe Price Blue Chip Growth Fund

Vanguard Asset Allocation

 

			
	 	* 	From September 20, 2002 — September 30, 2002, this investment was briefly named
the Putnam Global Growth Fund A as a result of the merger, in September 2002, of Putnam
Global Equity Fund A with Putnam Global Growth Fund A. The merged fund briefly retained
the name “Putnam Global Growth Fund A.” Effective October 1, 2002, the merged fund changed
its name to “Putnam Global Equity Fund A.”

7

 

SCHEDULE A

MEASUREMENT METHODS

(Effective January 11, 2003 to July 31, 2003)

Merck Common Stock

Mutual Funds

American Century Emerging Markets Institutional

American Funds EuroPacific Growth Fund

Fidelity Destiny I

Fidelity Dividend Growth

Fidelity Equity-Income

Fidelity Low-Priced Stock

Fidelity Retirement Money Market

Fidelity Spartan Government Income

Fidelity Spartan U.S. Equity Index

Franklin Small-Mid Cap Growth A

Janus Enterprise

Janus Growth & Income

Liberty Acorn Class Z

PIMCO Foreign Bond Institutional

PIMCO Long Term US Government Institutional

PIMCO Total Return Institutional

Putnam Global Equity A

Putnam International Capital Opportunities Fund A*

Putnam Vista A

T. Rowe Price Blue Chip Growth

Vanguard Asset Allocation

 

			
	*	 	Prior to April 30, 2003, known as Putnam International Voyager Fund A.

Redesignation of Deferred Amounts measured by Putnam Vista A on July 31, 2003

Prior to 4 p.m. ET on July 31, 2003, each participant who has any part of his/her account measured
by the Putnam Vista A measurement method may redesignate the amount in such measurement method in
accordance with Article IV. If a participant does not redesignate the amount measured by the
Putnam Vista A measurement method to any other remaining measurement method before 4 p.m. ET on
July 31, 2003, then the amount in the Putnam Vista A account shall be redesignated as of 4 p.m. ET
on July 31, 2003, to the Fidelity Mid-Cap Stock Fund.

8

 

SCHEDULE A

MEASUREMENT METHODS

(Effective
July 31, 2003 — November 19, 2003)

Merck Common Stock

Mutual Funds

American Century Emerging Markets Institutional

American Funds EuroPacific Growth Fund

Columbia Acorn Class Z*

Fidelity Destiny I

Fidelity Dividend Growth

Fidelity Equity-Income

Fidelity Low-Priced Stock

Fidelity Mid-Cap Stock Fund

Fidelity Retirement Money Market

Fidelity Spartan Government Income

Fidelity Spartan U.S. Equity Index

Franklin Small-Mid Cap Growth A

Janus Enterprise

Janus Growth & Income

PIMCO Foreign Bond Institutional

PIMCO Long Term US Government Institutional

PIMCO Total Return Institutional

Putnam Global Equity A

Putnam International Capital Opportunities Fund A**

T. Rowe Price Blue Chip Growth

Vanguard Asset Allocation

 

			
	*	 	Prior to October 2003, known as Liberty Acorn Class Z
	**	 	Prior to April 30, 2003, known as Putnam International Voyager Fund A

Redesignation of Deferred Amounts measured by Putnam Global Equity A and Putnam International
Capital Opportunities Fund A (collectively, the “Putnam Funds”) on November 19, 2003

Prior to 4 p.m. ET on November 19, 2003, each participant who has any part of his/her Deferred
Compensation Account measured by a Putnam Funds investment alternative may redesignate the amount
in such investment alternative in accordance with Article IV. If a participant does not
redesignate the amount measured by a Putnam Funds investment alternative to any other remaining
investment alternative(s) before 4 p.m. ET on November 19, 2003, then the amount in the Putnam
Funds investment alternative shall be redesignated as of 4 p.m. ET on November 19, 2003, to the
Fidelity Retirement Money Market Portfolio.

9

 

SCHEDULE A

MEASUREMENT METHODS

(November 19, 2003 to April 2, 2004)

Merck Common Stock

Mutual Funds

American Century Emerging Markets Institutional

American Funds EuroPacific Growth Fund

Columbia Acorn Class Z*

Fidelity Destiny I

Fidelity Dividend Growth

Fidelity Equity-Income

Fidelity Low-Priced Stock

Fidelity Mid-Cap Stock Fund

Fidelity Retirement Money Market

Fidelity Spartan Government Income

Fidelity Spartan U.S. Equity Index

Franklin Small-Mid Cap Growth A

Janus Enterprise

Janus Growth & Income

PIMCO Foreign Bond Institutional

PIMCO Long Term US Government Institutional

PIMCO Total Return Institutional

T. Rowe Price Blue Chip Growth

Vanguard Asset Allocation

 

			
	*	 	Prior to October 2003, known as Liberty Acorn Class Z.

4-02-04

10

 

SCHEDULE A

MEASUREMENT METHODS

(April 2, 2004 through January 31, 2005)

Merck Common Stock

Mutual Funds

American Century Emerging Markets Institutional

American Funds EuroPacific Growth Fund

Columbia Acorn Class Z*

Fidelity Destiny I

Fidelity Dividend Growth

Fidelity Equity-Income

Fidelity Low-Priced Stock

Fidelity Mid-Cap Stock Fund

Fidelity Retirement Money Market

Fidelity Spartan Government Income

Fidelity Spartan U.S. Equity Index

Janus Enterprise

Janus Growth & Income

PIMCO Foreign Bond Institutional

PIMCO Long Term US Government Institutional

PIMCO Total Return Institutional

T. Rowe Price Blue Chip Growth

Vanguard Asset Allocation

 

* Prior to October 2003, known as Liberty Acorn Class Z.

   4-02-04

11

 

SCHEDULE A

MEASUREMENT METHODS

(February 1, 2005)

Investment alternatives available under this plan shall be the same as the investment alternatives
available from time to time under the Merck & Co., Inc. Deferral Program.

12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00110-of-00352.parquet"}]]